Atellica IM BRAHMS Procalcitonin (PCT)

Atellica IM BRAHMS Procalcitonin (PCT) is an FDA 510(k)-cleared medical device (K181002) manufactured by Siemens Healthcare Diagnostics, Inc.. This device is classified under the Microbiology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on July 15, 2018. Regulation: 8.